Natalizumab is FDA-approved for the treatment of multiple sclerosis and Crohn's disease and approved for treatment of multiple sclerosis in Europe. Pre-clinical evidence suggests that it could be also used in combination for the treatment of B-cell malignancies where it overcomes the resistance to rituximab.
â¢ Maintains the security of the Dietary Department. â¢ Is responsible for knowing, understanding, and conveying to other dietary staff personnel the Federal and State rules and regulations regarding nursing home dietary requir ements and is responsible for their enforcement within the scope of the Dietary Department.
DCF, APD : For unlicensed staff, such as dietary and custodial staff, who work in a licensed general hospital, pursuant to Ch. 395, F.S., whose duties require them to work within a psychiatric unit/ward of the hospital, these staff and volunteers are required to comply with Level 2 background screening requirements.